tiprankstipranks
Vericel Corp (VCEL)
NASDAQ:VCEL
US Market

Vericel (VCEL) Earnings Dates, Call Summary & Reports

Compare
585 Followers

Earnings Data

Report Date
May 07, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
-0.13
Last Year’s EPS
-0.08
Same Quarter Last Year
Based on 7 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 27, 2025
|
% Change Since: -6.23%
|
Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Positive
Vericel Corporation reported a strong financial year in 2024 with significant revenue and profitability growth, particularly in the MACI and Burn Care franchises. The launch of MACI Arthro showed promising early indicators. However, challenges such as variability in Epicel's quarterly revenue and increased operating expenses were noted. Despite these challenges, the positive aspects significantly outweigh the lowlights.
Company Guidance
In the Vericel Corporation Fourth Quarter 2024 Conference Call, the company reported robust financial performance and set guidance for 2025. The company achieved a total revenue of over $237 million, reflecting a 20% growth from the previous year, with both the MACI and Burn Care franchises contributing significantly. The MACI franchise alone generated $197.3 million, showing a 21% year-over-year increase in Q4. Vericel's adjusted EBITDA rose to $53.4 million for the year, with a gross margin of 73% and an adjusted EBITDA margin of 23%. The company maintained a strong cash position, ending the year with $167 million in cash and no debt. For 2025, Vericel anticipates revenue growth of 20% to 23%, gross margins of 73% to 74%, and adjusted EBITDA margins of 25% to 26%. The launch of MACI Arthro and the expanded Burn Care sales force are expected to drive continued growth, with NexoBrid revenue projected to rise to high single-digit millions.
Strong Financial Performance in 2024
Vericel Corporation reported total revenue exceeding $237 million, marking a 20% growth, alongside a significant profit growth with adjusted EBITDA increasing to over $50 million and GAAP profitability of $10.4 million.
Record Quarterly Financial Results
The fourth quarter of 2024 saw record quarterly revenue of over $75 million, with a gross margin of 78%, adjusted EBITDA margin of 40%, and net income of nearly $20 million.
MACI Franchise Growth
MACI's revenue increased 21% year-over-year in Q4 and 20% for the full year, driven by strong fundamentals, including the highest number of MACI implants and biopsies since launch.
Burn Care Franchise Expansion
Burn Care revenue increased 22% to approximately $40 million for the full year, with underlying demand for Epicel and NexoBrid showing strong growth trends.
Promising MACI Arthro Launch
MACI Arthro's launch indicators are strong, with 250 trained surgeons and significant biopsy growth from trained surgeons, suggesting high market interest.
---

Vericel (VCEL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

VCEL Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 07, 20252025 (Q1)
-0.13 / -
-0.08
Feb 27, 20252024 (Q4)
0.32 / 0.38
0.2646.15% (+0.12)
Nov 07, 20242024 (Q3)
-0.05 / -0.02
-0.0875.00% (+0.06)
Aug 01, 20242024 (Q2)
-0.09 / -0.10
-0.119.09% (<+0.01)
May 08, 20242024 (Q1)
-0.11 / -0.08
-0.1650.00% (+0.08)
Feb 29, 20242023 (Q4)
0.17 / 0.26
0.12116.67% (+0.14)
Nov 08, 20232023 (Q3)
-0.12 / -0.08
-0.1442.86% (+0.06)
Aug 02, 20232023 (Q2)
-0.15 / -0.11
-0.1942.11% (+0.08)
May 10, 20232023 (Q1)
-0.15 / -0.16
-0.15-6.67% (-0.01)
Feb 23, 20232022 (Q4)
0.04 / 0.12
0.0933.33% (+0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

VCEL Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 27, 2025$52.85$49.62-6.11%
Nov 07, 2024$48.04$50.03+4.14%
Aug 01, 2024$50.52$47.52-5.94%
May 08, 2024$49.52$47.69-3.70%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Vericel Corp (VCEL) report earnings?
Vericel Corp (VCEL) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
    What is Vericel Corp (VCEL) earnings time?
    Vericel Corp (VCEL) earnings time is at May 07, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is VCEL EPS forecast?
          VCEL EPS forecast for the fiscal quarter 2025 (Q1) is -0.13.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis